The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index; none of the 99 sources its claims cite is checked for support yet.
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Open accessAbstract
Background/Aims: The diagnostic criteria for polycystic ovary syndrome (PCOS) in adolescence are controversial, primarily because the diagnostic pathological features used in adult women may be normal pubertal physiological events. Hence, international pediatric and adolescent specialty societies have defined criteria that have sufficient evidence to be used for the diagnosis of PCOS in adolescents. Methods: The literature has been reviewed and evidence graded to address a series of questions regarding the diagnosis of PCOS during adolescence including the following: clinical and biochemical evidence of hyperandrogenism, criteria for oligo-anovulation and polycystic ovary morphology, diagnostic criteria to exclude other causes of hyperandrogenism and amenorrhea, role of insulin resistance, and intervention. Results and Conclusion: Features of PCOS overlap normal pubertal development. Hence, caution should be taken before diagnosing PCOS without longitudinal evaluation. However, treatment may be indicated even in the absence of a definitive diagnosis. While obesity, insulin resistance, and hyperinsulinemia are common findings in adolescents with hyperandrogenism, these features should not be used to diagnose PCOS among adolescent girls.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 99 cited sources checked · 0 supported · 0 flagged
In the paper
“The diagnostic criteria for PCOS in adolescence are controversial, primarily because the diagnostic pathological features used in adult women, e.g.acne, irregular menses, and PCOM, may be normal pubertal physiological events [18]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Introduction
What the sources say
- Not checked yetcites [18] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“With the exception of one published recommendation, none of the current definitions of PCOS in adolescent or adult women include insulin resistance/hyperinsulinemia as a diagnostic criterion [1, 10-12, 18, 19, 112]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 6: What Is the Role of Insulin Resistance/Hyperinsulinemia in the Diagnosis of PCOS in Adolescents?
What the sources say
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“It is important to realize that about half of otherwise asymptomatic mild hirsutism is not associated with hyperandrogenemia [22,24]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“However, mild or focal hirsutism may be a sign of hyperandrogenemia in young women when associated with other evidence of PCOS, i.e., menstrual irregularity [29][30][31][32]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [29][30][31][32]
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Insulin resistance and hyperinsulinemia are intrinsic to PCOS in adults and adolescents, lean or obese.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 6: What Is the Role of Insulin Resistance/Hyperinsulinemia in the Diagnosis of PCOS in Adolescents?
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“The severity of hirsutism does not correlate well with circulating androgen concentrations [26]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [26] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“While obesity, insulin resistance, and hyperinsulinemia are common findings in adolescents with hyperandrogenism, these features should not be used to diagnose PCOS among adolescent girls.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Abstract
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Hyperinsulinemia is believed to exacerbate the hyperandrogenism and the reproductive and metabolic manifestations of PCOS in adolescents.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 6: What Is the Role of Insulin Resistance/Hyperinsulinemia in the Diagnosis of PCOS in Adolescents?
What the sources say
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“All adult PCOS criteria consider hirsutism as evidence of clinical hyperandrogenism.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [10][11][12]
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Features of PCOS overlap normal pubertal development.”
- Also stated in: § Introduction · hedged
“the diagnostic pathological features used in adult women, e.g.acne, irregular menses, and PCOM, may be normal pubertal physiological events [18]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Abstract
What the sources say
- Not checked yetcites [18] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § Introduction · hedged
- Probably not a substantial claim. 12
- It may state two separate claims as one. 21
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, insulin resistance and/ or hyperinsulinemia should not be used to diagnose PCOS among adolescent girls.”
- Also stated in: § Recommendations · plain
“Although prevalent among adolescents at risk for PCOS, insulin resistance and hyperinsulinemia should not be utilized as diagnostic criteria (Level B).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Introduction
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Also stated in: § Recommendations · plain
None of the sources cited for this claim have been checked yet.
In the paper
“Upper lip scores of 3-4 were found in <3% of Black and White US adolescents, though scores of 1-2 rose in prevalence from 7.3% at <2 years after menarche to 28.2% at >2 years after menarche [40,41]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Even though hirsutism is common among women with hyperandrogenism, the latter can occur in the absence of cutaneous manifestations [2,3]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Biochemical evidence of hyperandrogenism, as indicated by persistent elevation of serum total and/or free testosterone levels and determined in a reliable reference laboratory, provides the clearest support for the presence of hyperandrogenism in an adolescent girl with symptoms of PCOS (Level B).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Recommendations
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“PCOM, variously defined, has been reported with a prevalence of 30-40% (range between 26 and 54%) and has been described in healthy girls [82]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Is the Prevalence of PCOM in Adolescents?
What the sources say
- Not checked yetcites [82] source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“weight loss, treatment with metformin, or treatment with rosiglitazone were associated with improved insulin sensitivity and attenuation of hyperandrogenemia in some studies [133][134][135][136][137]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 6: What Is the Role of Insulin Resistance/Hyperinsulinemia in the Diagnosis of PCOS in Adolescents?
What the sources say
- Not checked yetcites [133][134][135][136][137]
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Further, a multifollicular pattern, which is defined by the presence of large follicles distributed throughout the ovary, does not have a relationship with hyperandrogenism, is more common in adolescents, and should not be considered a pathological finding (Level C).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Hormonal Findings Are Associated with Polycystic Ovaries?
What the sources say
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“a population-based study from Australia of adolescents considered to have PCOS in which increased free testosterone concentration was the factor most predictive of insulin resistance, while menstrual irregularities and polycystic ovaries were not associated with insulin resistance [127]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 6: What Is the Role of Insulin Resistance/Hyperinsulinemia in the Diagnosis of PCOS in Adolescents?
What the sources say
- Not checked yetcites [127] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Menstrual irregularity is common among adolescents and is generally the result of anovulatory cycles.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 3: What Are the Criteria for Evidence of Oligo-Anovulation in Adolescents?
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Although morning 17-OHP concentrations (>200 ng/dl) have been reported as being more common in women with CAH (87%), over 20% of women with PCOS had elevated morning 17-OHP values [110]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 5: What Diagnostic Procedures Are Appropriate in Adolescents to Exclude Other Causes of Hyperandrogenism and Amenorrhea?
What the sources say
- Not checked yetcites [110] source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Regular cycles (21-45 days) are established by the third year after menarche in approximately 95% of girls, but cycles can remain irregular until the fifth year.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 3: What Are the Criteria for Evidence of Oligo-Anovulation in Adolescents?
What the sources say
- Not checked yetcites [64][65][66][67]
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Accordingly, the persistence of oligomenorrhea (menstrual cycles longer than 45 days), secondary amenorrhea (absence of cycles for more than 3 months), or primary amenorrhea in girls with complete pubertal development and adult stature suggests the coexistence of androgen excess [71,78]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 3: What Are the Criteria for Evidence of Oligo-Anovulation in Adolescents?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“While comedonal acne is common in adolescent girls, moderate or severe comedonal acne (i.e., 10 or more facial lesions) in early puberty or moderate inflammatory acne through the perimenarcheal years is uncommon (<5% prevalence) [42,43]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 1: What Are the Criteria for Clinical Evidence of Clinical Hyperandrogenism in the Adolescent Girl?
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moderate to severe hirsutism constitutes clinical evidence of hyperandrogenism (Level B).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Recommendations
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“The reported prevalence for NCAH is 1 in 1,000 with an increased prevalence in specific ethnic groups [99]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 5: What Diagnostic Procedures Are Appropriate in Adolescents to Exclude Other Causes of Hyperandrogenism and Amenorrhea?
What the sources say
- Not checked yetcites [99] source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Legro et al. [69] found that over 90% of adolescent females have 10 or more menstrual cycles per year (average menstrual interval 36.5 days) 3 years after menarche.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 3: What Are the Criteria for Evidence of Oligo-Anovulation in Adolescents?
What the sources say
- Not checked yetcites [69] source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Follow-up of a different group of unselected healthy adolescents for 12 years showed tracking of androgen levels into adulthood; higher levels in adolescence were associated with lower fertility, suggesting evolving PCOS [59]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 2: What Are the Criteria for Evidence of Biochemical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [59] source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Follicle counts should not be utilized to define PCOM in adolescents (Level B).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Hormonal Findings Are Associated with Polycystic Ovaries?
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“No compelling criteria to define PCOM have been established for adolescents.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Hormonal Findings Are Associated with Polycystic Ovaries?
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
- Rests on an assumption: No compelling criteria to define polycystic ovary morphology have been established for adolescents.
In the paper
“In a study of unselected schoolgirls with oligomenorrhea, 4% had hirsutism and 57% had elevated testosterone levels [58]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 2: What Are the Criteria for Evidence of Biochemical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [58] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Until further research establishes definitive criteria, an ovarian volume >12.0 cm 3 (by formula for a prolate ellipsoid) can be considered en-”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Hormonal Findings Are Associated with Polycystic Ovaries?
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Lack of onset of menses by age 15 years or by more than 2-3 years after thelarche regardless of chronologic age is statistically uncommon and warrants evaluation and consideration of diagnoses such as PCOS (Level B).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Recommendations
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For these reasons, testosterone concentrations should be considered elevated when they are persistently greater than the adult female normative values according to assays performed by specialty laboratories with welldefined reference intervals.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 2: What Are the Criteria for Evidence of Biochemical Hyperandrogenism in the Adolescent Girl?
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A single androgen level >2 SD above the mean for the specific assay should not be considered to be evidence of hyperandrogenism in an otherwise asymptomatic adolescent girl (Level C).”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Recommendations
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
In the paper
“Hence, PCOM is an inconsistent finding and does not invariably predict the development of PCOS [82]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > What Is the Prevalence of PCOM in Adolescents?
What the sources say
- Not checked yetcites [82] source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Gambineri et al. [61] defined hyperandrogenism during the follicular phase as total testosterone concentrations >42 ng/dl using a LC-MS/MS assay.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 2: What Are the Criteria for Evidence of Biochemical Hyperandrogenism in the Adolescent Girl?
What the sources say
- Not checked yetcites [61] source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“These trials have also shown improvements related to hirsutism, ovulation, quality of life, sleep, lipid profile, adipocytokine levels, and insulin resistance [148-160]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 7: Does a Diagnosis of PCOS during Adolescence Provide an Opportunity for Meaningful Intervention? What Are the Risks of Overdiagnosis?
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A diagnosis of PCOS can impact an adolescent's quality of life; this diagnosis can create early and unwarranted anxiety about future fertility for the young women and her family.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 7: Does a Diagnosis of PCOS during Adolescence Provide an Opportunity for Meaningful Intervention? What Are the Risks of Overdiagnosis?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“PCOS is a common heterogeneous phenotype with features overlapping some features characteristic of normal pubertal development.”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Summary
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Longer duration trials (12 months or more) are very limited and are either open-labelled trials or lack placebocontrolled arms [133, 135, 161-163]”
§ The Diagnosis of Polycystic Ovary Syndrome during Adolescence > Question 7: Does a Diagnosis of PCOS during Adolescence Provide an Opportunity for Meaningful Intervention? What Are the Risks of Overdiagnosis?
What the sources say
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
No consensus exists on the clinical criteria for diagnosing androgen excess in adolescence.
“No consensus exists on the clinical criteria to reach the diagnosis of androgen excess in adolescence.”
The paper relies on this without support.
The definition of persistent oligomenorrhea is uncertain.
“However, the definition of 'persistent oligomenorrhea' is uncertain.”
The paper relies on this without support.
Detailed data are not available regarding the accuracy of predicting ongoing hyperandrogenic anovulation from a single elevated testosterone level.
“However, detailed data are not available regarding the accuracy of the prediction of ongoing hyperandrogenic anovulation from a single elevated testosterone level.”
The paper relies on this without support.
No data are available indicating how long hyperandrogenemia must continue to accurately predict persistence and development of polycystic ovary syndrome in adulthood.
“Further, no data are available indicating how long hyperandrogenemia must continue to accurately predict persistence and development of PCOS in adulthood.”
The paper relies on this without support.
No compelling criteria to define polycystic ovary morphology have been established for adolescents.
“No compelling criteria to define PCOM have been established for adolescents.”
The paper relies on this without support.
Available data are inconsistent regarding the usefulness of anti-Müllerian hormone in the diagnosis of polycystic ovary syndrome among adolescent girls.
“Available data are inconsistent regarding the usefulness of AMH in the diagnosis of PCOS among adolescent girls [92][93][94][95][96]”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Often each clinical symptom and comorbidity is treated separately, which can delay or obscure a diagnosis of PCOS and limit follow up care [3, 22, 23].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [23]
Experimental — accuracy not yet measuredIn the citing paper
“These similarities between normal pubertal development and the clinical features associated with PCOS confound the diagnosis in adolescent girls (Table 1) [125–127].”
From Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls (2019) · cites this paper as [127]
In the citing paper
“However, delineating appropriate diagnostic criteria for PCOS among adolescent girls has been problematic because irregular menses, cystic acne, mild hyperandrogenism, and multifollicular ovarian morphology occur during normal pubertal maturation.”
From Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls (2019) · cites this paper as [127]
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Barker, D. J. P., Hales, C. N., Fall, C. H. D., Osmond, C., Phipps, K., & Clark, P. M. S. (1993) · Diabetologia · doi:10.1007/bf00399095 · Cited by 2,468
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Self-citationDabelea, D., Hanson, R. L., Lindsay, R. S., Pettitt, D. J., Imperatore, G., Gabir, M. M., Roumain, J., Bennett, P. H., & Knowler, W. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2208 · Cited by 1,277
Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., & Raff, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1864 · Cited by 1,176
Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132
Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
Chen, Z.-J., Zhao, H., He, L., Shi, Y., Qin, Y., Shi, Y., Li, Z., You, L., Zhao, J., Liu, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.732 · Cited by 782
Flagged first, then by citations
Research works printed but not linked: 110
- 10.1016/j.fertnstert.2011.09.024 · DOI · Paper page
- 10.1210/jc.2005-1457 · DOI · Paper page
- 10.1038/ijo.2008.61 · DOI
- 10.1210/me.13.6.946 · DOI · Paper page
- 10.1038/nrendo.2014.58 · DOI · Paper page
- 10.1016/j.fertnstert.2003.10.004 · DOI · Paper page
- 10.1016/j.fertnstert.2008.06.035 · DOI · Paper page
- 10.1111/j.1365-2265.2007.02764.x · DOI · Paper page
- 10.1093/humrep/der418 · DOI · Paper page
- 10.1016/j.ajog.2010.03.008 · DOI · Paper page
- 10.1210/jc.2013-2350 · DOI · Paper page
- 10.1210/jc.2006-0178 · DOI · Paper page
- 10.1136/qhc.12.1.18 · DOI · Paper page
- 10.1210/er.21.4.363 · DOI
- 10.1210/jc.2007-2437 · DOI
- 10.1590/S0004-27302011000800013 · DOI · Paper page
- 10.1093/humupd/dmp024 · DOI · Paper page
- 10.3109/09513590.2013.797399 · DOI
- 10.4161/derm.1.2.8354 · DOI · Paper page
- 10.1016/j.jpag.2009.03.007 · DOI
- 10.1016/j.ajog.2004.06.064 · DOI
- 10.1016/j.fertnstert.2009.02.056 · DOI
- 10.1111/j.1524-4725.2012.02462.x · DOI
- 10.1001/archderm.135.6.656 · DOI
- 10.1016/j.fertnstert.2011.06.040 · DOI
- 10.1210/jc.2004-2301 · DOI
- 10.1016/j.bpobgyn.2004.05.007 · DOI
- 10.1136/jfprhc-2011-100175 · DOI
- 10.1067/mpd.2001.109790 · DOI
- 10.1210/jcem-21-11-1440 · DOI
- 10.1016/S0022-3476(97)70307-X · DOI
- 10.1542/peds.2013-0490B · DOI
- 10.1210/jc.2010-1123 · DOI · Paper page
- 10.1016/j.fertnstert.2013.12.056 · DOI
- 10.1210/jc.84.10.3666 · DOI · Paper page
- 10.1210/jc.2013-3399 · DOI
- 10.1016/S0022-3476(83)80678-7 · DOI
- 10.1210/jcem.85.4.6543 · DOI
- 10.1210/jc.2008-2771 · DOI
- 10.1210/jc.2013-1770 · DOI
- 10.1210/jcem-45-5-1039 · DOI
- 10.1093/humrep/14.9.2223 · DOI
- 10.1210/jcem-71-4-970 · DOI
- 10.1203/00006450-199512000-00024 · DOI
- 10.1210/jc.2012-3537 · DOI
- 10.1677/joe.0.0970213 · DOI
- 10.1016/S1043-2760(98)00020-4 · DOI · Paper page
- 10.1210/jc.2007-1846 · DOI · Paper page
- 10.1093/humrep/deh079 · DOI · Paper page
- 10.1097/00006254-196608000-00009 · DOI
- 10.1136/adc.44.235.291 · DOI · Paper page
- 10.1542/peds.2006-2481 · DOI · Paper page
- 10.1016/S0197-0070(86)80014-6 · DOI
- 10.1053/beem.2002.0203 · DOI · Paper page
- 10.1093/humrep/der102 · DOI
- 10.1016/S0140-6736(85)92552-8 · DOI
- 10.1016/j.fertnstert.2010.06.015 · DOI · Paper page
- 10.1515/jpem-2012-0014 · DOI
- 10.1210/jc.2014-3336 · DOI
- 10.1371/journal.pone.0071465 · DOI
- 10.1016/j.jpag.2013.11.007 · DOI · Paper page
- 10.1007/s00330-009-1643-8 · DOI
- 10.1016/j.fertnstert.2009.11.002 · DOI
- 10.1093/humrep/der223 · DOI
- 10.1093/humupd/dmt062 · DOI
- 10.1515/jpem-2012-0013 · DOI
- 10.1016/j.ejogrb.2014.06.018 · DOI
- 10.1016/j.steroids.2011.12.009 · DOI
- 10.1155/2010/625105 · DOI
- 10.1111/j.1365-2362.2011.02550.x · DOI
- 10.1080/09513590701297708 · DOI
- 10.4274/Jcrpe.835 · DOI
- 10.1210/jc.86.1.207 · DOI · Paper page
- 10.1016/j.fertnstert.2006.04.015 · DOI · Paper page
- 10.1067/mpd.2001.109603 · DOI · Paper page
- 10.1210/jcem.80.10.7559882 · DOI
- 10.1210/jcem.84.12.6341 · DOI · Paper page
- 10.1016/j.metabol.2005.11.003 · DOI · Paper page
- 10.1210/jc.2005-1666 · DOI
- 10.1210/jc.2008-1198 · DOI · Paper page
- 10.1016/j.fertnstert.2013.12.046 · DOI
- 10.1016/j.jpeds.2012.11.019 · DOI
- 10.1016/j.fertnstert.2011.03.001 · DOI
- 10.1210/jc.87.3.1017 · DOI · Paper page
- 10.1080/09513590802630146 · DOI
- 10.1210/jcem-62-5-904 · DOI
- 10.1210/edrv.18.6.0318 · DOI
- 10.1046/j.1365-2265.1999.00770.x · DOI
- 10.1210/jc.87.4.1555 · DOI · Paper page
- 10.1016/S1054-139X(01)00202-6 · DOI
- 10.1093/humrep/del185 · DOI
- 10.1210/jc.2010-2547 · DOI
- 10.1210/jc.2005-0438 · DOI · Paper page
- 10.1210/jcem.86.8.7756 · DOI · Paper page
- 10.1210/jc.2003-031848 · DOI
- 10.1136/adc.2004.053959 · DOI
- 10.1210/jc.2006-2002 · DOI
- 10.1515/JPEM.2005.18.8.761 · DOI · Paper page
- 10.1001/archpedi.160.3.241 · DOI · Paper page
- 10.1210/jc.2008-0461 · DOI · Paper page
- 10.1016/j.jpag.2013.09.011 · DOI · Paper page
- 10.1210/jcem.86.8.7756 · DOI · Paper page
- 10.1016/j.fertnstert.2009.08.006 · DOI · Paper page
- 10.1016/j.jpag.2014.01.004 · DOI
- 10.1111/cen.12028 · DOI
- 10.1210/jc.2003-031281 · DOI
- 10.1210/jc.2011-1609 · DOI · Paper page
- 10.1080/713603060 · DOI · Paper page
- 10.1210/jc.2013-1041 · DOI · Paper page
- 10.1016/S0015-0282(02)02993-X · DOI · Paper page
Cited by
Sorted by citations
Items 101–174 of 174
Tefagh, G., Payab, M., Qorbani, M., Sharifi, F., Sharifi, Y., Ebrahimnegad Shirvani, M. S., Pourghazi, F., Atlasi, R., Shadman, Z., Rezaei, N., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09082-3 · Cited by 102
The relation of sugar intake to β cell function in overweight Latino children
Davis, J. N., Ventura, E. E., Weigensberg, M. J., Ball, G. D., Cruz, M. L., Shaibi, G. Q., & Goran, M. I. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.5.1004 · Cited by 101
Shomaker, L. B., Tanofsky-Kraff, M., Zocca, J. M., Courville, A., Kozlosky, M., Columbo, K. M., Wolkoff, L. E., Brady, S. M., Crocker, M. K., Ali, A. H., et al. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29812 · Cited by 101
Benelli, E., Del Ghianda, S., Di Cosmo, C., & Tonacchera, M. (2016) · International Journal of Endocrinology · doi:10.1155/2016/3204083 · Cited by 100
Vitonis, A. F., Baer, H. J., Hankinson, S. E., Laufer, M. R., & Missmer, S. A. (2010) · Human Reproduction · doi:10.1093/humrep/deq039 · Cited by 98
Gower, B. A., & Goss, A. M. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.195065 · Cited by 98
Goodrich, J. A., Walker, D. I., He, J., Lin, X., Baumert, B. O., Hu, X., Alderete, T. L., Chen, Z., Valvi, D., Fuentes, Z. C., et al. (2023) · Environmental Health Perspectives · doi:10.1289/ehp11372 · Cited by 96
PCOS Physiopathology and Vitamin D Deficiency: Biological Insights and Perspectives for Treatment
Morgante, G., Darino, I., Spanò, A., Luisi, S., Luddi, A., Piomboni, P., Governini, L., & De Leo, V. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154509 · Cited by 95
Kamenov, Z., & Gateva, A. (2020) · Molecules · doi:10.3390/molecules25235566 · Cited by 100
Castellanos-Ryan, N., Parent, S., Vitaro, F., Tremblay, R. E., & Séguin, J. R. (2013) · Journal of Abnormal Psychology · doi:10.1037/a0033133 · Cited by 94
Berns, G. S., Moore, S., & Capra, C. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006773 · Cited by 91
Xu, J., Bishop, C. V., Lawson, M. S., Park, B. S., & Xu, F. (2016) · Human Reproduction · doi:10.1093/humrep/dew100 · Cited by 90
Cree-Green, M., Rahat, H., Newcomer, B. R., Bergman, B. C., Brown, M. S., Coe, G. V., Newnes, L., Garcia-Reyes, Y., Bacon, S., Thurston, J. E., et al. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00192 · Cited by 82
Biochemical and genetic diagnosis of 21-hydroxylase deficiency
Falhammar, H., Wedell, A., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0731-6 · Cited by 80
Profiles of 21-Carbon Steroids in 21-Hydroxylase Deficiency
Turcu, A. F., Rege, J., Chomic, R., Liu, J., Nishimoto, H. K., Else, T., Moraitis, A. G., Palapattu, G. S., Rainey, W. E., & Auchus, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1023 · Cited by 77
Real-life insights on menstrual cycles and ovulation using big data
Soumpasis, I., Grace, B., & Johnson, S. (2020) · Human Reproduction Open · doi:10.1093/hropen/hoaa011 · Cited by 76
Yilmaz, M., Biri, A., Karakoç, A., Törüner, F., Bingöl, B., Çakir, N., Tiras, B., Ayvaz, G., & Arslan, M. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345339 · Cited by 77
Günalan, E., Yaba, A., & Yılmaz, B. (2018) · Journal of the Turkish-German Gynecological Association · doi:10.4274/jtgga.2018.0077 · Cited by 74
An Update on Contraception in Polycystic Ovary Syndrome
Oguz, S. H., & Yildiz, B. O. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.958 · Cited by 76
Vizza, L., Smith, C. A., Swaraj, S., Agho, K., & Cheema, B. S. (2016) · BMC Sports Science, Medicine and Rehabilitation · doi:10.1186/s13102-016-0039-8 · Cited by 74
Ismayilova, M., & Yaya, S. (2022) · BMC Women's Health · doi:10.1186/s12905-022-01630-3 · Cited by 68
Riedl, S., Röhl, F.-W., Bonfig, W., Brämswig, J., Richter-Unruh, A., Fricke-Otto, S., Bettendorf, M., Riepe, F., Kriegshäuser, G., Schönau, E., et al. (2019) · Endocrine Connections · doi:10.1530/ec-18-0281 · Cited by 69
Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance
Herman, R., Sikonja, J., Jensterle, M., Janez, A., & Dolzan, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043140 · Cited by 69
Helfrich-Förster, C., Monecke, S., Spiousas, I., Hovestadt, T., Mitesser, O., & Wehr, T. A. (2021) · Science Advances · doi:10.1126/sciadv.abe1358 · Cited by 70
Cardiometabolic Risk in PCOS: More than a Reproductive Disorder
Torchen, L. C. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0956-2 · Cited by 65
Interventions for hirsutism (excluding laser and photoepilation therapy alone)
van Zuuren, E. J., Fedorowicz, Z., Carter, B., & Pandis, N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010334.pub2 · Cited by 65
McCullough, D., Webb, R., Enright, K. J., Lane, K. E., McVeigh, J., Stewart, C. E., & Davies, I. G. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09616-y · Cited by 62
Where Have the Periods Gone? The Evaluation and Management of Functional Hypothalamic Amenorrhea
Sophie Gibson, M. E., Fleming, N., Zuijdwijk, C., & Dumont, T. (2020) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2019.2019.s0178 · Cited by 61
Complex diseases and co-morbidities: polycystic ovary syndrome and type 2 diabetes mellitus
Rodgers, R. J., Avery, J. C., Moore, V. M., Davies, M. J., Azziz, R., Stener-Victorin, E., Moran, L. J., Robertson, S. A., Stepto, N. K., Norman, R. J., et al. (2019) · Endocrine Connections · doi:10.1530/ec-18-0502 · Cited by 60
Weight management interventions in women with and without PCOS: a systematic review
Kataoka, J., Tassone, E., Misso, M., Joham, A., Stener-Victorin, E., Teede, H., & Moran, L. (2017) · Nutrients · doi:10.3390/nu9090996 · Cited by 58
Sydora, B. C., Wilke, M. S., McPherson, M., Chambers, S., Ghosh, M., & Vine, D. F. (2023) · BMC Women's Health · doi:10.1186/s12905-023-02732-2 · Cited by 60
“” see multiple physicians or specialists, get 2nd opinion 32 [23.5] ◦ “Find a physician / dietician / therapist, etc. that specializes with PCOS patients.”
BackgroundInfluentialHyperinsulinaemic androgen excess in adolescent girls
Ibáñez, L., Ong, K. K., López-Bermejo, A., Dunger, D. B., & de Zegher, F. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.58 · Cited by 56
Self-citationHealthy post-menarchal adolescent girls demonstrate multi-level reproductive axis immaturity
Sun, B. Z., Kangarloo, T., Adams, J. M., Sluss, P. M., Welt, C. K., Chandler, D. W., Zava, D. T., McGrath, J. A., Umbach, D. M., Hall, J. E., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00595 · Cited by 55
Kim, J. Y., Tfayli, H., Michaliszyn, S. F., & Arslanian, S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01958 · Cited by 55
Self-citationAnti-Müllerian hormone in obese adolescent girls with polycystic ovary syndrome
Kim, J. Y., Tfayli, H., Michaliszyn, S. F., Lee, S., Nasr, A., & Arslanian, S. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2016.10.015 · Cited by 54
Shah, D., Patil, M., & On behalf of the National PCOS Working Group (2018) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_72_18 · Cited by 51
Holte, J. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350784 · Cited by 52
A randomized pilot study of dietary treatments for polycystic ovary syndrome in adolescents
Wong, J. M. W., Gallagher, M., Gooding, H., Feldman, H. A., Gordon, C. M., Ludwig, D. S., & Ebbeling, C. B. (2016) · Pediatric Obesity · doi:10.1111/ijpo.12047 · Cited by 50
Moran, L., Grieger, J., Mishra, G., & Teede, H. (2015) · Nutrients · doi:10.3390/nu7105419 · Cited by 49
Polak, A. M., Adamska, A., Krentowska, A., Łebkowska, A., Hryniewicka, J., Adamski, M., & Kowalska, I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030732 · Cited by 48
Mario, F. M., Graff, S. K., & Spritzer, P. M. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0570-1 · Cited by 47
A life course perspective on polycystic ovary syndrome
Sanchez, N. (2014) · International Journal of Women's Health · doi:10.2147/ijwh.s55748 · Cited by 43
Ovarian and extra-ovarian mediators in the development of polycystic ovary syndrome
Puttabyatappa, M., & Padmanabhan, V. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0079 · Cited by 43
Zhu, S., Li, Z., Hu, C., Sun, F., Wang, C., Yuan, H., & Li, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.697223 · Cited by 41
Dorn, L. D., Beal, S. J., Kalkwarf, H. J., Pabst, S., Noll, J. G., & Susman, E. J. (2013) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2012.10.005 · Cited by 40
Haimov-Kochman, R., & Berger, I. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00191 · Cited by 40
PCOS in Adolescence and Type 2 Diabetes
Carreau, A.-M., & Baillargeon, J.-P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-014-0564-3 · Cited by 40
Trier, C., Hollensted, M., Schnurr, T. M., Lund, M. A. V., Nielsen, T. R. H., Rui, G., Andersson, E. A., Svendstrup, M., Bille, D. S., Gjesing, A. P., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-020-00673-6 · Cited by 38
Soldat-Stanković, V., Popović-Pejičić, S., Stanković, S., Prtina, A., Malešević, G., Bjekić-Macut, J., Livadas, S., Ognjanović, S., Mastorakos, G., Micić, D., et al. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01691-5 · Cited by 37
Pandurevic, S., Mancini, I., Mitselman, D., Magagnoli, M., Teglia, R., Fazzeri, R., Dionese, P., Cecchetti, C., Caprio, M., Moretti, C., et al. (2023) · Endocrine Connections · doi:10.1530/ec-22-0536 · Cited by 36
Examination of the interpersonal model of loss of control eating in the laboratory
Shank, L. M., Crosby, R. D., Grammer, A. C., Shomaker, L. B., Vannucci, A., Burke, N. L., Stojek, M., Brady, S. M., Kozlosky, M., Reynolds, J. C., et al. (2017) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2017.03.015 · Cited by 35
Calcaterra, V., Magenes, V. C., Massini, G., De Sanctis, L., Fabiano, V., & Zuccotti, G. (2024) · Nutrients · doi:10.3390/nu16070938 · Cited by 35
Turcu, A. F., El-Maouche, D., Zhao, L., Nanba, A. T., Gaynor, A., Veeraraghavan, P., Auchus, R. J., & Merke, D. P. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0129 · Cited by 33
Reid, B. M., Miller, B. S., Dorn, L. D., Desjardins, C., Donzella, B., & Gunnar, M. (2017) · Pediatric Research · doi:10.1038/pr.2017.35 · Cited by 31
Childhood obesity and the associated roles of neighborhood and biologic stress
Theall, K. P., Chaparro, M. P., Denstel, K., Bilfield, A., & Drury, S. S. (2019) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2019.100849 · Cited by 29
Calcaterra, V., Cena, H., Sottotetti, F., Hruby, C., Madini, N., Zelaschi, N., & Zuccotti, G. (2023) · Nutrients · doi:10.3390/nu15163582 · Cited by 27
Metabolic effects of polycystic ovary syndrome in adolescents
Han, Y., Kim, H. S., Lee, H.-J., Oh, J.-Y., & Sung, Y.-A. (2015) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2015.20.3.136 · Cited by 22
Zelinska, N., Shevchenko, I., & Globa, E. (2018) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.5119 · Cited by 21
Is cardiorespiratory fitness impaired in PCOS women? A review of the literature
Donà, S., Bacchi, E., & Moghetti, P. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0599-1 · Cited by 20
Wang, F., Dou, P., Wei, W., & Liu, P. J. (2024) · Nutrition & Diabetes · doi:10.1038/s41387-024-00263-9 · Cited by 20
Gambineri, A., & Zanotti, L. (2018) · Nucleus · doi:10.1080/19491034.2018.1509659 · Cited by 19
Sheikh, J., Khalil, H., Shaikh, S., Hebbar, M., Zia, N., Wicks, S., Jayaprakash, S., Narendran, A., Subramanian, A., Malhotra, K., et al. (2023) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17428 · Cited by 18
Leung, W. T., Tang, Z., Feng, Y., Guan, H., Huang, Z., & Zhang, W. (2022) · Nutrients · doi:10.3390/nu14245285 · Cited by 17
Vine, D. F., Beilin, L. J., Burrows, S., Huang, R.-C., Hickey, M., Hart, R., Proctor, S. D., & Mori, T. A. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa061 · Cited by 17
Prevalence of iron deficiency using 3 definitions among women in the US and Canada
Barton, J. C., Wiener, H. W., Barton, J. C., & Acton, R. T. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.13967 · Cited by 15
Tokmak, A., Timur, H., Aksoy, R. T., Çınar, M., & Yılmaz, N. (2015) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.21549 · Cited by 15
Dörr, H.-G., Schulze, N., Bettendorf, M., Binder, G., Bonfig, W., Denzer, C., Dunstheimer, D., Salzgeber, K., Schmidt, H., Schwab, K. O., et al. (2020) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-020-00100-w · Cited by 14
Xing, N.-N., Ren, F., & Yang, H. (2024) · Food & Nutrition Research · doi:10.29219/fnr.v68.9835 · Cited by 13
Dallora, A. L., Kvist, O., Berglund, J. S., Ruiz, S. D., Boldt, M., Flodmark, C.-E., & Anderberg, P. (2020) · JMIR Medical Informatics · doi:10.2196/18846 · Cited by 13
Polycystic ovarian morphology is associated with primary dysmenorrhea in young Korean women
Jeong, J. Y., Kim, M. K., Lee, I., Yun, J., Won, Y. B., Yun, B. H., Seo, S. K., Cho, S., Choi, Y. S., & Lee, B. S. (2019) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2019.62.5.329 · Cited by 11
Skoranski, A., Kelly, N. R., Radin, R. M., Thompson, K. A., Galescu, O., Demidowich, A. P., Brady, S. M., Chen, K. Y., Tanofsky-Kraff, M., Yanovski, J. A., et al. (2018) · Journal of Child and Family Studies · doi:10.1007/s10826-018-1065-9 · Cited by 10
Kim, N., & Chun, S. (2021) · Clinical and Experimental Reproductive Medicine · doi:10.5653/cerm.2021.04553 · Cited by 10
Kanney, N., Patki, A., Chandler-Laney, P., Garvey, W. T., & Hidalgo, B. A. (2022) · Metabolites · doi:10.3390/metabo12121226 · Cited by 10
Wang, Y., Xiang, T., Xia, X., Zhang, H., Geng, S., Yang, G., Qiu, S., He, Y., Liu, R., Li, L., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1010714 · Cited by 5
Metadata
- Authors
- Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., Tfayli, H., Arslanian, S., Dabadghao, P., Garcia Rudaz, C., & Lee, P. A.
- Affiliations
- Children's Hospital of Pittsburgh (US)
- Morgan Stanley Children's Hospital (US)
- University of Chicago (US)
- Nationwide Children's Hospital (US)
- Hospital Sant Joan de Déu Barcelona (ES)
- National Center For Child Health and Development (JP)
- Baylor College of Medicine (US)
- American University of Beirut Medical Center (LB)
- University of Pittsburgh (US)
- Sanjay Gandhi Post Graduate Institute of Medical Sciences (IN)
- Pennsylvania State University (US)
- ORCID
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 83
- Issue
- 6
- Pages
- 376-389
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2053105417
- Cited by
- 3,113
- References
- 67
- Citations by year
- 2026: 17 · 2025: 119 · 2024: 197 · 2023: 328 · 2022: 357 · 2021: 237 · 2020: 231 · 2019: 276 · 2018: 244 · 2017: 223 · 2016: 206 · 2015: 187
- FWCI
- 43.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hormone Research in Paediatrics (publishedVersion)
- PubMed (publishedVersion)
- Universidad de Chile (submittedVersion, cc-by-nc-nd)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605)
- National Center for Research Resources (M01RR010732)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Keywords
- polycystic ovary syndrome, adolescents, diagnostic criteria, hyperandrogenism, oligoanovulation, polycystic ovary morphology, insulin resistance, hyperinsulinemia, obesity, amenorrhea, longitudinal assessment
- MeSH terms
- Adolescent, Female, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Puberty, Hyperandrogenism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
